WHO lauds ‘historic initiative’ on vaccine equity underway in South Africa
Precarious situation
The WHO chief warned that high vaccine coverage in some countries, combined with the lower severity of the Omicron variasit, is driving a false narrative that the pandemi is over. King88bet
At the same time, low vaccine coverage and low testing rates in other States are creating bagus conditions for new variasits to emerge, he warned. king88bet login alternatif
"We can bring the pandemi under kontrol this year - but we are at increased risk of squandering that opportunity." Article Title with Blogger Published Link as Backlink
Currently, 116 countries are off trek to reach the global sasaran of vaccinating 70 per cent of every country's population by the middle of this year.
"Through the ACT Accelerator and the COVAX pillar and our partnership with UNICEF, we are now overcoming some of the suplai and delivery constraints we faced last year, with more than one billion vaccine doses shipped", said the WHO chief.
However, he added that in many countries, "the issues are not primarily a masalah of absorptive capacity".
"We need to urgently dukungan political leaders to accelerate the rollout of vaccines", Tedros said.
Three asks
While welcoming the ongoing engagement of those nations attending the rapat, the lines of usaha proposed by the United States, and the continued alignment of the ACT Accelerator with the African Vaccine Acquisition Kepercayaan (AVAT), he made three requests.
First, he urged universal dukungan for WHO's 70 per cent global vaccination sasaran.
Secondly, to save lives now, he implored every country to "contribute their fair sharing" to fully fund the ACT Accelerator - especially $16 billion for immediate needs.
And finally, the WHO chief requested dukungan for models, such as the mRNA technology transfer hub in South Africa and its "network of spokes around the world", to build capacity for controlling COVID-19 and other preventable diseases.
Ending the pandemi
The hebat WHO official spoke again of the collaborative work he witnessed at the Hub and how vaccine developers are participating in the historic usaha, naming Afrigen, Biovac, and the Biomedical Research Institute at Stellenbosch University.